31![In Silico Models for Screening New Drugs for QT Prolongation Potential using Human Clinical Trial Data OpenTox USA 2013 Innovation in Predictive Toxicology October 30, 2013 In Silico Models for Screening New Drugs for QT Prolongation Potential using Human Clinical Trial Data OpenTox USA 2013 Innovation in Predictive Toxicology October 30, 2013](https://www.pdfsearch.io/img/8177024ce35fb46d5535606b6c3b94d3.jpg) | Add to Reading ListSource URL: www.opentox.orgLanguage: English - Date: 2014-02-05 08:06:48
|
---|
32![Briefing Package - Errata Briefing Package - Errata](https://www.pdfsearch.io/img/5f732353dc1feb23950fe7b5525ba30c.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
33![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may](https://www.pdfsearch.io/img/64aba835ad29003340bf7268b53c538e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
34![L. Steven Leshin: Pharmacology and Toxicology L. Steven Leshin: Pharmacology and Toxicology](https://www.pdfsearch.io/img/a8999104239fb3b64c105df1b1bf37ae.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
35![Docket 04D-0377, ICH E a , linical Evaluation of QT Prolonga iat Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation ATTACHMENT Page 14 Docket 04D-0377, ICH E a , linical Evaluation of QT Prolonga iat Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation ATTACHMENT Page 14](https://www.pdfsearch.io/img/60c1ba63748202dcc2a404bb8b896728.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-12-27 14:03:22
|
---|
36![0 (#I@Bristol-Myers Squibb Company Richard L. W uth, Ph.D. Senior Vice President 0 (#I@Bristol-Myers Squibb Company Richard L. W uth, Ph.D. Senior Vice President](https://www.pdfsearch.io/img/8a44d5ccf6276e82d20cacfea8bd49a5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-01-05 16:25:56
|
---|
37![Pfizer Inc Worldwide Regulatory Affairs and Quality Assurance 50 Pequot Avenue New London, Connecticut[removed]I . Pfizer Inc Worldwide Regulatory Affairs and Quality Assurance 50 Pequot Avenue New London, Connecticut[removed]I .](https://www.pdfsearch.io/img/a8df17719cfcd7c0bac00b02fec6e158.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-01-05 16:25:56
|
---|
38![Schering-Plough Research Institute . I Schering-Plough Research Institute . I](https://www.pdfsearch.io/img/bd32a397934a015027a19d85ea80b5d5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-01-05 16:25:55
|
---|
39![,,‘ /II,” A’ December 13,2004 Management Dockets, N/A ,,‘ /II,” A’ December 13,2004 Management Dockets, N/A](https://www.pdfsearch.io/img/f2f626b93a86065257029ea8c40abe1c.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
40![Guidance for Industry S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals Guidance for Industry S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals](https://www.pdfsearch.io/img/50ff64bcb666fdbdf8091d9dc55e984f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-10-17 17:55:35
|
---|